Literature DB >> 23884753

Discriminating pheochromocytomas from other adrenal lesions: the dilemma of elevated catecholamines.

Jennifer C Carr1, Philip M Spanheimer, Maheen Rajput, Fadi S Dahdaleh, Geeta Lal, Ronald J Weigel, Sonia L Sugg, Junlin Liao, James R Howe.   

Abstract

BACKGROUND: Screening tests for pheochromocytoma involve measuring levels of catecholamines in the urine or plasma, which have significant false-positive rates. We reviewed patients with adrenal masses and elevated levels of catecholamines to determine the value of different preoperative tests in diagnosing pheochromocytomas.
METHODS: A retrospective chart review identified patients who underwent adrenalectomy between 1997 and 2011 with elevation of urine or serum catecholamines. A database of clinicopathologic factors was created including preoperative urine and plasma metanephrines, normetanephrines, vanillylmandelic acid, and fractionated catecholamines, and tumor dimensions on imaging and pathology.
RESULTS: A total of 70 patients underwent adrenalectomy because of presence of an adrenal mass and elevation of catecholamines or normetanephrines or metanephrines. Of these, 46 had pathologically confirmed pheochromocytomas. To improve our ability to discriminate between pheochromocytoma and other pathology, we examined different combinations of clinicopathologic factors and catecholamine levels and found the best test was a scoring system. Points are awarded for a hierarchy of elevated normetanephrine, norepinephrine, metanephrines, with additional points received for age <50 and size on imaging >3.3 cm. A score of 2 is suggestive of pheochromocytoma, with a positive predictive value of 86-87%, while a score of 4 is diagnostic with positive predictive value of 100%.
CONCLUSION: We found that urine/serum normetanephrine levels were the most valuable screening tool; however, a score examining the size of adrenal mass on preoperative CT, age, and either plasma or urine norepinephrine, metanephrine, and normetanephrine values leads to a higher positive predictive value, making this scoring system superior to individual lab tests.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23884753      PMCID: PMC4270467          DOI: 10.1245/s10434-013-3142-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  19 in total

1.  Pheochromocytoma.

Authors:  W F KVALE; W M MANGER; J T PRIESTLEY; G M ROTH
Journal:  Circulation       Date:  1956-10       Impact factor: 29.690

2.  Chemical screening methods for the diagnosis of pheochromocytoma. I. Nor-epinephrine and epinephrine in human urine.

Authors:  M GOLDENBERG; I SERLIN; T EDWARDS; M M RAPPORT
Journal:  Am J Med       Date:  1954-03       Impact factor: 4.965

3.  Diagnostic value of increased urinary output of pheochromocytoma.

Authors:  A ENGEL; U S von EULER
Journal:  Lancet       Date:  1950-09-23       Impact factor: 79.321

4.  The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients.

Authors:  G H Anderson; N Blakeman; D H Streeten
Journal:  J Hypertens       Date:  1994-05       Impact factor: 4.844

Review 5.  Adrenal masses: mr imaging features with pathologic correlation.

Authors:  Khaled M Elsayes; Govind Mukundan; Vamsidhar R Narra; James S Lewis; Ali Shirkhoda; Aamer Farooki; Jeffrey J Brown
Journal:  Radiographics       Date:  2004-10       Impact factor: 5.333

6.  A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines.

Authors:  Anna M Sawka; Roman Jaeschke; Ravinder J Singh; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

Review 7.  High blood pressure. A side effect of drugs, poisons, and food.

Authors:  F H Messerli; E D Frohlich
Journal:  Arch Intern Med       Date:  1979-06

8.  Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.

Authors:  Graeme Eisenhofer; David S Goldstein; McClellan M Walther; Peter Friberg; Jacques W M Lenders; Harry R Keiser; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

9.  Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma.

Authors:  Peter E Hickman; Michelle Leong; Julia Chang; Susan R Wilson; Brett McWhinney
Journal:  Pathology       Date:  2009-02       Impact factor: 5.306

Review 10.  Clonidine suppression test revisited.

Authors:  T Lenz; A Ross; P Schumm-Draeger; K L Schulte; H Geiger
Journal:  Blood Press       Date:  1998-05       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.